Getein Biotech Inc(603387) ( Getein Biotech Inc(603387) ) announced on April 8 that the company signed the investment intention agreement with star medical Holdings (2393. HK), and the parties reached a preliminary intention on the company’s subscription of the newly issued shares of star medical in cash. After this subscription, the company will hold no less than 30% of the total shares of star medical after the issuance of new shares, and the company will become the controlling shareholder of star medical, and star medical will become the consolidated subsidiary of the company. After the completion of this transaction, the company can form synergy and complementarity with the existing distribution and marketing platform of star medical, which will effectively enrich the resources of the company’s medical institutions.